EUDA Scientific Committee
Please note: on Tuesday 2 July 2024, the EMCDDA became the European Union Drugs Agency (EUDA), with an extended remit and stronger role. Some pages on our website may not yet reflect this change but will be updated shortly.
Introduction
The task of the Scientific Committee is to assist the Management Board and the Director of the EUDA by delivering an opinion on any scientific matter concerning the Centre's activity which the Management Board or the Director may submit to it. In addition, the risk assessment of new psychoactive substances is carried out by the Scientific Committee, in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended by regulation (EU) 2017/2101).
About
The EUDA Scientific Committee is set up by Article 13 of Regulation (EC) No 1920/2006 of the European Parliament and of the Council on the European Monitoring Centre for Drugs and Drug Addiction (as amended by regulation (EU) 2017/2101).
The task of the Scientific Committee is to assist the Management Board and the Director of the EUDA by delivering an opinion on any scientific matter concerning the Centre's activity which the Management Board or the Director may submit to it. In addition, the risk assessment of new psychoactive substances is carried out by the Scientific Committee, in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended by regulation (EU) 2017/2101).
The Committee consists of fifteen well-known scientists appointed by the Management Board in view of their scientific excellence and their independence, following a publication of a call for expressions of interest in the Official Journal of the European Union. The selection procedure ensures that the specialist fields of the members of the Scientific Committee cover the most relevant scientific fields linked to the problems of drug and drug addiction. The members of the Scientific Committee are appointed in a personal capacity and give their opinions completely independently of the Member States and the Community Institutions and serve for a three-year period (renewable).
The Scientific Committee is requested by the EUDA founding regulation to give a formal opinion on the EUDA programming documents on the basis of a draft submitted by the Centre's Director before it is presented to the Management Board. The Scientific Committee reviews many of the EUDA publications with regard to their scientific quality, plays an important role in the risk assessment of new psychoactive substances and supports the different working areas of the EUDA. Since its constitution, the Scientific Committee has established itself as an important pillar of the EUDA’s institutional life, ensuring the scientific legitimacy of the Agency and providing for continuous improvement of the main outputs.
Minutes from recent Scientific Committee meetings and other reference documents are available under Documents.
Rules of procedure of the EMCDDA Scientific Committee.
Documents
Members
Scientific field | Photo | Member | Affiliation | Nationality | Specific expertise | Documents |
---|---|---|---|---|---|---|
Basic biological, neurobiological and behavioural research | Prof. Dr Demetrovics, Zsolt | ELTE Eötvös Loránd University (Budapest, Hungary)
|
Hungarian | Addiction Research, Epidemiology |
|
|
Demand reduction and public health | Prof. Dr Clausen, Thomas | Norwegian Centre for Addiction Research, University of Oslo, Norway |
Norwegian | Addiction Research, Prevention of health consequences of drug use |
|
|
Demand reduction and public health | Prof. Dr Ferrer-Wreder, Laura | Department of Psychology, Stockholm University |
Swedish | Addiction Research, Clinical psychology |
|
|
Demand reduction and public health | Prof. Dr Torrens , Marta | Universitat Pompeu Fabra Barcelona, Spain |
Spanish | Psychiatry, Public health |
|
|
Demand reduction and public health | Prof. Dr Fischer, Gabriele | Department of Psychiatry & Psychotherapy, Medical University, Vienna, Austria |
Austrian | Psychiatry |
|
|
Drug policy | Dr Jauffret-Roustide, Marie | Inserm (French Institute of Health and Medical Research), Paris, France |
French | Sociology, Public health, Harm reduction |
|
|
Drug policy | Prof. Dr Mario Baldacchino, Alexander | University of St Andrews, Scotland, UK | Maltese | Addiction Research, Drug policy, Psychiatry |
|
|
Population-based research and epidemiology | Prof. Dr Sypsa, Vana | Medical School, National and Kapodistrian University of Athens, Greece | Greek | Epidemiology, Healthcare statistics |
|
|
Population-based research and epidemiology | Prof. Dr Lintonen, Tomi | Finnish Foundation for Alcohol Studies, Helsinki, Finland |
Finnish | Health promotion, Epidemiology, Public health |
|
|
Population-based research and epidemiology | Prof. Dr Auwärter, Volker | University of Freiburg, Institute of Forensic Medicine, Germany | German | Pharmacology & Toxicology |
|
|
Population-based research and epidemiology | Prof. Dr Comiskey, Catherine | Trinity College Dublin, The University of Dublin |
Irish | Mathematics, Healthcare statistics |
|
|
Supply, supply reduction and crime | Prof. Dr Liem, Marieke | Institute of Security and Global Affairs, Leiden University, The Netherlands |
Dutch | Criminology, Clinical psychology |
|
|
Supply, supply reduction and crime | Prof. Dr Colman, Charlotte | Department of Criminology, Criminal Law & Social Law, Ghent University, Belgium |
Belgian | Drug policy, Criminology |
|
|
Supply, supply reduction and crime | Dr Giommoni, Luca | Cardiff University, UK | Italian | Drug supply markets |
|